Stable Isotope Labelled Enfortumab Biosimilar – Anti-PVRL4 mAb – Research Grade

Reference: PX-TA1333-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Enfortumab Biosimilar - Anti-PVRL4 mAb - Research Grade
SourceCAS 1346452-25-2
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsAGS-22CE,AGS-22M,AGS-22M6E,unconjugated:AGS-22C3 or AGSM6
ReferencePX-TA1333-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Enfortumab Biosimilar - Anti-PVRL4 mAb - Research Grade

General information on Anti-PVRL4[Homo sapiens] (Enfortumab) Monoclonal Antibody

Enfortumab is a human monoclonal antibody that targets Nectin-4. It has been used as an antibody drug conjugate (ADC), Enfortumab vedotin to treat patients with advanced, treatment-resistant urothelial cancers.It has been marketed under the tradename Padcev.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Enfortumab Biosimilar – Anti-PVRL4 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products